LABT · Lakewood-Amedex Biotherapeutics Inc.
Substantial doubt about the company's ability to continue as a going concern.
“As a result, substantial doubt regarding the Company’s ability to continue as a going concern within one year after the date that these financial statements are issued has not been alleviated.”View the 10-Q filed May 22, 2026
Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
|
2026-07-31
Scheduled
FINRA publishes Aug 11
|
— | — | — | — |
| 2026-07-15 | 24,029 | 37,772 | -13,743 | 1.00 |
| 2026-06-30 | 37,772 | 73,164 | -35,392 | 1.00 |
| 2026-06-15 | 7,316 | 3,902 | +3,415 | 1.00 |
| 2026-05-29 | 3,902 | 14,855 | -10,953 | 1.00 |
| 2026-05-15 | 14,855 | 7,571 | +7,284 | 1.00 |
| 2026-04-30 | 7,571 | 0 | +7,571 | 1.00 |